
51 - 200 employees
Founded 2016
🧬 Biotechnology
💊 Pharmaceuticals
Biotechnology • Pharmaceuticals
Immunic Therapeutics is a late-stage biotechnology company focused on developing novel, orally administered small-molecule therapies for chronic inflammatory and autoimmune diseases, with particular programs targeting multiple sclerosis and celiac disease. The company advances differentiated clinical-stage programs (e. g. , vidofludimus calcium, IMU-856, IMU-381) aiming to provide efficacious, safe, and well-tolerated oral treatment options for neurologic and gastrointestinal immune-mediated conditions, while pursuing regulatory protections and commercialization pathways.
🔥 3 hours ago
National Director of Field Medical for Immunic overseeing MS field medical organization. Building and leading a high-performing team to align with Medical Affairs objectives.